1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Is Lee...

Discussion in 'Takeda IT' started by Anonymous, May 8, 2011 at 7:16 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Is Lee still thinking of us?





    ...........................
     
  2. Anonymous

    Anonymous Guest



    Who cares. Like anyone else left there he ought to be thinking about where his paycheck will be coming from once Actos goes generic.
     
  3. Anonymous

    Anonymous Guest

    Money well pocketed from big A. Who cares. The 3 cronies got their friends and their pockets full.